Iba et al demonstrated a favorable trend for AT supplement at a dosage of 3000 IU/day over 1500 IU/day for the treatment of sepsis-associated DIC. 13 In the treatment of Septic DIC, it may be necessary to adjust the optimal dose, taking into account not only the difference in source of infection, but also the severity of the patient’s illness and the status of coagulation-fibrinolytic disruption.
← all excerpts
Prognostic Impact of Therapeutic Agents for Septic-Associated Disseminated Intravascular Coagulation According to Different Sources of Infection.
1
—
—